SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. The company is headquartered in Eden Prairie, Minnesota and currently employs 46 full-time employees. The company went IPO on 2008-11-07. The company is a provider of wound care products. The company is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. The company applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
最新の財務諸表(Form-10K)によると、SANUWAVE Health Incの総資産は$0で、純損失は$0です。
SNWVの主要な財務比率は何ですか?
SANUWAVE Health Incの流動比率は0、純利益率は0、1株当たり売上高は$0です。
SANUWAVE Health Incの収益はセグメントまたは地域別にどのように分けられていますか?
SANUWAVE Health Inc の最大収益セグメントは Consumable and Parts で、最新の利益発表における収益は 13,222,000 です。地域別に見ると、United States が SANUWAVE Health Inc の主要市場であり、収益は 20,168,000 です。